Authors
Latest:
The Future of Periodontal TreatmentAdvancements in periodontal disease could make way for expansions in the dental space and other medical fields.
Latest:
Remote Reliance: The Rise of Oncology Home CareWhile hurdles remain, home healthcare could deliver better patient-centered cancer care—providing improved outcomes, enhanced quality of life, and reduced strain on resources.
Latest:
Biopharma Needs a Health System Strategy to Secure Optimal Market AccessIn today’s pharmaceutical market access landscape, payers are not the sole decision-makers in utilization management development.
Latest:
Patient-Centricity in Biopharma: Selling Health Versus PillsDevesh Verma and Rebecca Lorenzo outline some the challenges and potential solutions to building a patient-centric culture
Latest:
IDMP in a COVID ContextLise Stevens explores what difference the ISO IDMP (Identification of Medicinal Products) data standards would have made in a COVID-19 context — in applications ranging from pharmacovigilance adverse event reporting and electronic prescribing to falsified medicines control.
Latest:
Why the Pandemic is Rewriting the Biopharma Rule BookChanges necessitated by COVID will drive unprecedented transformation of industry.
Latest:
China’s 2022 NRDL OutlookThe 2022 National Reimbursement Drug List will see more pressures for new inclusions on the one hand, and more certainties for renewals on the other. At the same time, the process is becoming more interactive and transparent.
Latest:
A Brand Game-Changer? TikTok and Pharma MarketingIt’s time for pharma brands to recognize the potential of TikTok as a promotional platform and develop a strategy to not only stand out but make an impact.
Latest:
Climbing Health Care Costs Result in Elevated Employer VigilanceSoaring healthcare costs show little sign of slowing in 2024, with concerns growing about the affordability of medications and medical services.
Latest:
Are We Forgetting to Develop Vaccines for Diseases other than COVID?It's time to apply the same COVID-19 urgency to other devastating diseases, such as Alzheimer’s, write Andrea Pfeifer and William Mobley.
Latest:
3 ASCO Insights for Pharma CommunicatorsThe world’s largest cancer research meeting, the American Society of Clinical Oncology (ASCO) Annual Meeting, recently convened in person in Chicago after two years of being held virtually. Sara Baker and Kristine Austria Fan of Marina Maher Communications provide their takeaways from the meeting.
Latest:
Building Pharma and Lab Spaces in New Jersey 2021–Adapting to Changing NeedsNJ can regain leadership in pharma by offering modern lab spaces for biotech and other lab-based growth companies.
Latest:
Key Factors Attributing to a Successful Product LaunchWhat the c-suite should consider in today’s marketplace.
Latest:
Pharma’s Business Case for RWE: Tapping the Full Value From These InsightsHow drugmakers can better harness real-world evidence to drive their clinical and commercial objectives, while also providing greater clarity for healthcare providers and improved access to therapy for the patients they serve.
Latest:
A Culture of Quality: The Catalyst to Accelerate InnovationWhy enabling a shared culture of quality across an organization is key to maintaining pharma’s recent pace of innovation wins—while inspiring new levels of confidence.
Latest:
The Real Cost of State Drug Importation Programs? Patient SafetyImporting drugs from Canada may increase the risk of US citizens being exposed to unsafe medicines.
Latest:
From Potential to Value: Carving a Slice of the CGT ‘PIE'The importance of pre-approval information exchange (PIE) with payers and other strategic considerations to help navigate today’s market access challenges and regulatory requirements in bringing promising cell and gene therapies to the market.
Latest:
Three Keys to Ireland’s Resilient Pharma IndustryRecent growth in pharma makes Ireland an ideal candidate for expansion opportunities.
Latest:
The Resilience of R&D: Pharma Posted Record Output in 2021Despite disruption from the COVID-19 pandemic still in full swing, life sciences innovation activity remained undeterred, a recent report from the IQVIA Institute for Human Data Science finds—outlining the key factors driving record-breaking growth.
Latest:
Recent Federal Circuit Developments in Patent LicensingUnderstanding of recent legal developments can help companies avoid infringement.
Latest:
With Project Optimus, Success Favors the PreparedOncology drug developers must start asking questions in preparation of FDA’s dose optimization initiative.
Latest:
Achieving Diverse Teams for a Diverse WorldThe benefits of diversity in the workplace are far-reaching — not just for employees, but for a company’s overall health.
Latest:
Say Hello to Flexible: Reimagining the Patient JourneyThrough embracing connected and tech-enabled services and devices, new avenues and opportunities exist for greater clinical trial flexibility in drug research.
Latest:
Cold Chain: Delivering Innovative Specialty Pharmaceutical ProductsRafael Teixeira on building an end-to-end cold chain strategy to support global storage and distribution efforts.
Latest:
Doing More With Less: How Automation is Reshaping Drug SafetyBetter technology is redefining pharmacovigilance as it expands beyond its traditional compliance focus to become a key business differentiator.
